DOCSLIB.ORG

Acetylene Hydratase from Pelobacter Acetylenicus : Functional Studies On

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acetylene Hydratase from Pelobacter Acetylenicus : Functional Studies On Acetylene Hydratase from Pelobacter acetylenicus Functional Studies on a Gas-Processing Tungsten, Iron-Sulfur Enzyme by Site Directed Mutagenesis and Crystallography Dissertation zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften Dr. rer. nat. vorgelegt von Dipl.-Biol. Felix ten Brink Konstanz, April 2010 1. Referent: Prof. Dr. P.M.H. Kroneck 2. Referent: Prof. Dr. O. Einsle Datum der mündlichen Prüfung: 09.04.2010 II Table of contents Table of contents Table of contents ....................................................................................................................I Zusammenfassung ................................................................................................................ V Summary.............................................................................................................................VII 1. Introduction ................................................................................................................... 1 1.1 Molybdenum and tungsten in biological systems ................................................. 1 Chemical properties and bioavailability of molybdenum and tungsten ........................ 1 Molybdenum and tungsten in organisms....................................................................... 2 Molybdenum and tungsten enzymes ............................................................................. 3 Molybdenum cofactor and enzyme classification ......................................................... 4 Heterologous expression of molybdopterin-dependent enzymes.................................. 7 Cofactor biosynthesis in Escherichia coli ..................................................................... 8 Chaperone mediated cofactor delivery........................................................................ 10 1.2 Iron sulfur clusters............................................................................................... 11 Cluster biosynthesis..................................................................................................... 12 1.3 Acetylene............................................................................................................. 13 Reactions of Acetylene................................................................................................ 14 Sources and bio-availability ........................................................................................ 15 1.4 Acetylene Hydratase from Pelobacter acetylenicus............................................ 16 Overall structure .......................................................................................................... 17 Active site.................................................................................................................... 18 Reaction mechanism.................................................................................................... 19 1.5 Scope of the study ............................................................................................... 20 2. Materials and Methods ................................................................................................ 23 2.1 Chemicals and biochemicals ............................................................................... 23 2.2 Acetylene Hydratase from P. acetylenicus.......................................................... 24 Cultivation of P. acetylenicus...................................................................................... 24 Purification .................................................................................................................. 25 Crystallization.............................................................................................................. 26 2.3 Heterologous Expression of AH in E. coli .......................................................... 30 Cloning ........................................................................................................................ 30 I Table of contents Transformation............................................................................................................ 30 Test expressions .......................................................................................................... 31 Addition of chaperone binding sites............................................................................ 32 Site directed mutagenesis............................................................................................ 33 Cultivation and expression of AH variants ................................................................. 34 Purification of AH variants ......................................................................................... 34 Crystallization of NarG-AH........................................................................................ 35 2.4 Further methods................................................................................................... 36 Experiments under exclusion of dioxygen.................................................................. 36 Determination of protein concentration ...................................................................... 36 Enzyme activity........................................................................................................... 37 SDS-PAGE.................................................................................................................. 38 Agarose gel electrophoresis ........................................................................................ 39 Qualitative and quantitative analysis of molybdenum cofactor.................................. 39 UV/Vis spectroscopy................................................................................................... 39 Circular dichroism spectroscopy................................................................................. 40 Metal analysis by ICP-MS .......................................................................................... 40 Sequence alignments................................................................................................... 40 3. Results ......................................................................................................................... 42 3.1 Acetylene Hydratase from P. acetylenicus ......................................................... 42 Cultivation................................................................................................................... 42 Purification.................................................................................................................. 43 Crystallization of acetylene hydratase from P. acetylenicus....................................... 45 3.2 Heterologous expression of AH in E. coli........................................................... 52 Addition of chaperone binding sites............................................................................ 53 Site directed mutagenesis............................................................................................ 54 Cultivation and expression of AH variants ................................................................. 56 Purification of heterologously expressed AH ............................................................. 57 Characterization of AH and variants........................................................................... 60 Molecular parameters of heterologously expressed AH and variants......................... 60 Crystallization of heterologously expressed NarG-AH .............................................. 66 4. Discussion ................................................................................................................... 68 Influence of MPD on activity of AH........................................................................... 68 II Table of contents 4.1 Crystallization of AH(W) and AH(Mo) .............................................................. 69 Incubation of crystals with C2H2 and CO.................................................................... 69 Soaking with acetaldehyde and propargylalcohol....................................................... 72 Crystallization of AH(Mo) .......................................................................................... 73 4.2 Expression of AH in E. coli................................................................................. 74 Molybdenum cofactor insertion and addition of chaperone binding sequences ......... 77 Control of protein folding with circular dichroism spectroscopy................................ 79 Site directed mutagenesis ............................................................................................ 81 Metal content and activity ........................................................................................... 82 Reaction mechanism and substrate binding..................................................................... 84 5. Conclusions ................................................................................................................. 87 5.1 Reactivity in crystallo................................................................................................ 87 5.2 Site directed mutagenesis of amino acid residues at the active site .......................... 87 6. References ................................................................................................................... 89 7. Acknowledgements ....................................................................................................
Load more

Recommended publications
  • 35 Disorders of Purine and Pyrimidine Metabolism
    35 Disorders of Purine and Pyrimidine Metabolism Georges van den Berghe, M.- Françoise Vincent, Sandrine Marie 35.1 Inborn Errors of Purine Metabolism – 435 35.1.1 Phosphoribosyl Pyrophosphate Synthetase Superactivity – 435 35.1.2 Adenylosuccinase Deficiency – 436 35.1.3 AICA-Ribosiduria – 437 35.1.4 Muscle AMP Deaminase Deficiency – 437 35.1.5 Adenosine Deaminase Deficiency – 438 35.1.6 Adenosine Deaminase Superactivity – 439 35.1.7 Purine Nucleoside Phosphorylase Deficiency – 440 35.1.8 Xanthine Oxidase Deficiency – 440 35.1.9 Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency – 441 35.1.10 Adenine Phosphoribosyltransferase Deficiency – 442 35.1.11 Deoxyguanosine Kinase Deficiency – 442 35.2 Inborn Errors of Pyrimidine Metabolism – 445 35.2.1 UMP Synthase Deficiency (Hereditary Orotic Aciduria) – 445 35.2.2 Dihydropyrimidine Dehydrogenase Deficiency – 445 35.2.3 Dihydropyrimidinase Deficiency – 446 35.2.4 Ureidopropionase Deficiency – 446 35.2.5 Pyrimidine 5’-Nucleotidase Deficiency – 446 35.2.6 Cytosolic 5’-Nucleotidase Superactivity – 447 35.2.7 Thymidine Phosphorylase Deficiency – 447 35.2.8 Thymidine Kinase Deficiency – 447 References – 447 434 Chapter 35 · Disorders of Purine and Pyrimidine Metabolism Purine Metabolism Purine nucleotides are essential cellular constituents 4 The catabolic pathway starts from GMP, IMP and which intervene in energy transfer, metabolic regula- AMP, and produces uric acid, a poorly soluble tion, and synthesis of DNA and RNA. Purine metabo- compound, which tends to crystallize once its lism can be divided into three pathways: plasma concentration surpasses 6.5–7 mg/dl (0.38– 4 The biosynthetic pathway, often termed de novo, 0.47 mmol/l). starts with the formation of phosphoribosyl pyro- 4 The salvage pathway utilizes the purine bases, gua- phosphate (PRPP) and leads to the synthesis of nine, hypoxanthine and adenine, which are pro- inosine monophosphate (IMP).
    [Show full text]
  • Review Article
    Free Radical Biology & Medicine, Vol. 33, No. 6, pp. 774–797, 2002 Copyright © 2002 Elsevier Science Inc. Printed in the USA. All rights reserved 0891-5849/02/$–see front matter PII S0891-5849(02)00956-5 Review Article STRUCTURE AND FUNCTION OF XANTHINE OXIDOREDUCTASE: WHERE ARE WE NOW? ROGER HARRISON Department of Biology and Biochemistry, University of Bath, Bath, UK (Received 11 February 2002; Accepted 16 May 2002) Abstract—Xanthine oxidoreductase (XOR) is a complex molybdoflavoenzyme, present in milk and many other tissues, which has been studied for over 100 years. While it is generally recognized as a key enzyme in purine catabolism, its structural complexity and specialized tissue distribution suggest other functions that have never been fully identified. The publication, just over 20 years ago, of a hypothesis implicating XOR in ischemia-reperfusion injury focused research attention on the enzyme and its ability to generate reactive oxygen species (ROS). Since that time a great deal more information has been obtained concerning the tissue distribution, structure, and enzymology of XOR, particularly the human enzyme. XOR is subject to both pre- and post-translational control by a range of mechanisms in response to hormones, cytokines, and oxygen tension. Of special interest has been the finding that XOR can catalyze the reduction of nitrates and nitrites to nitric oxide (NO), acting as a source of both NO and peroxynitrite. The concept of a widely distributed and highly regulated enzyme capable of generating both ROS and NO is intriguing in both physiological and pathological contexts. The details of these recent findings, their pathophysiological implications, and the requirements for future research are addressed in this review.
    [Show full text]
  • Quantum Chemical Cluster Modeling of Enzymatic Reactions Rong-Zhen
    Quantum Chemical Cluster Modeling of Enzymatic Reactions Rong-Zhen Liao 1 Rong-Zhen Liao, Stockholm, 2010 ISBN 978-91-7447-129-8 Printed in Sweden by US-AB, Stockholm 2010 Distributor: Department of Organic Chemistry, Stockholm University 2 3 4 Abstract The Quantum chemical cluster approach has been shown to be quite powerful and efficient in the modeling of enzyme active sites and reaction mechanisms. In this thesis, the reaction mechanisms of several enzymes have been investigated using the hybrid density functional B3LYP. The enzymes studied include four dinuclear zinc enzymes, namely dihydroorotase, N-acyl-homoserine lactone hydrolase, RNase Z, and human renal dipeptidase, two trinuclear zinc enzymes, namely phospholipase C and nuclease P1, two tungstoenzymes, namely formaldehyde ferredoxin oxidoreductase and acetylene hydratase, aspartate α-decarboxylase, and mycolic acid cyclopropane synthase. The potential energy profiles for various mechanistic scenarios have been calculated and analyzed. The role of the metal ions as well as important active site residues has been discussed. In the cluster approach, the effects of the parts of the enzyme that are not explicitly included in the model are taken into account using implicit solvation methods. With aspartate α-decarboxylase as an example, systematic evaluation of the solvation effects with the increase of the model size has been performed. At a model size of 150-200 atoms, the solvation effects almost vanish and the choice of the dielectric constant becomes rather insignificant. For all six zinc-dependent enzymes studied, the di-zinc bridging hydroxide has been shown to be capable of performing nucleophilic attack on the substrate. In addition, one, two, or even all three zinc ions participate in the stabilization of the negative charge in the transition states and intermediates, thereby lowering the barriers.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2013/0059868 A1 Miner Et Al
    US 2013 0059868A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0059868 A1 Miner et al. (43) Pub. Date: Mar. 7, 2013 (54) TREATMENT OF GOUT Publication Classification (75) Inventors: Jeffrey Miner, San Diego, CA (US); Jean-Luc Girardet, San Diego, CA (51) Int. Cl. (US); Barry D. Quart, Encinitas, CA A613 L/496 (2006.01) (US) A6IP 29/00 (2006.01) (73) Assignee: Ardea Biociences, Inc., San Diego, CA A6IP 9/06 (2006.01) (US) A613 L/426 (2006.01) A 6LX3/59 (2006.01) (21) Appl. No.: 13/637,343 (52) U.S. Cl. ...................... 514/262.1: 514/384: 514/365 (22) PCT Fled: Mar. 29, 2011 (86) PCT NO.: PCT/US11A3O364 (57) ABSTRACT S371 (c)(1), (2), (4) Date: Oct. 24, 2012 Sodium 2-(5-bromo-4-(4-cyclopropyl-naphthalen-1-yl)-4H Related U.S. Application Data 1,2,4-triazol-3-ylthio)acetate is described. In addition, phar (60) Provisional application No. 61/319,014, filed on Mar. maceutical compositions and uses Such compositions for the 30, 2010. treatment of a variety of diseases and conditions. Patent Application Publication Mar. 7, 2013 Sheet 1 of 10 US 2013/00598.68A1 FIGURE 1 S. C SOC 55000 40 S. s 3. s Patent Application Publication Mar. 7, 2013 Sheet 2 of 10 US 2013/00598.68A1 ~~~::CC©>???>©><!--->?©><??--~~~~~·%~~}--~~~~~~~~*~~~~~~~~·;--~~~~~~~~~;~~~~~~~~~~}--~~~~~~~~*~~~~~~~~;·~~~~~ |×.> |||—||--~~~~ ¿*|¡ MSU No IL-1ra MSU50 IL-1ra MSU 100 IL-1ra MSU500 IL-1ra cells Only No IL-1 ra Patent Application Publication Mar. 7, 2013 Sheet 3 of 10 US 2013/00598.68A1 FIGURE 3 A: 50000 40000 R 30000 2 20000 10000 O -7 -6 -5 -4 -3 Lesinurad (log)M B: Lesinurad (log)M Patent Application Publication Mar.
    [Show full text]
  • UNIVERSITY of EMBU EDWARD NDERITU KARANJA Phd 2020
    UNIVERSITY OF EMBU EDWARD NDERITU KARANJA PhD 2020 MICROBIAL COMMUNITY DIVERSITY AND STRUCTURE WITHIN ORGANIC AND CONVENTIONAL FARMING SYSTEMS IN CENTRAL HIGHLANDS OF KENYA EDWARD NDERITU KARANJA (MSc) A THESIS SUBMITTED IN PARTIAL FULFILLMENT FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN APPLIED MICROBIOLOGY IN THE UNIVERSITY OF EMBU NOVEMBER, 2020 DECLARATION This thesis is my original work and has not been presented for a degree in any other University Signature……………………………. Date………….……….. Edward Nderitu Karanja Department of Biological Science B801/147/2015 This thesis has been submitted for examination with our approval as the University Supervisors Signature……………………………. Date………….………. Prof. Romano Mwirichia Department of Biological science University of Embu (UoEm), Kenya Signature………. …………………………. Date………….…………. Dr. Andreas Fliessbach Department of Soil Science Research Institute of Organic Agriculture - FIBL, Switzerland i DEDICATION I dedicated to my family; my wife Anne Kelly Kambura, my children; Shawn Karanja, Melissa Wangithi, Joseph Munyuithia, Shayne Koome and Ann Wanjiku, my parents; Mr. Samuel Karanja and Mrs. Agnes Wangithi, my siblings, Ruth Wairimu, Juliet Muthoni, Alex Ngochi, James Karuma and Nelly Njoki. I appreciate the support you have accorded me during my studies. Your inspiration and backing in this journey made it easier to manage all challenges encountered. ii ACKNOWLEDGEMENT I express gratitude toward Almighty God for his mercies from the beginning of this long and thought-provoking journey. This was conducted in the framework of long-term systems comparison program, with financial support from Biovision Foundation, Coop Sustainability Fund, Liechtenstein Development Service (LED) and the Swiss Agency for Development and Cooperation (SDC). I acknowledge icipe core funding for the kind contribution provided by UK-Aid from UK Government, Swedish International Development Cooperation Agency, Swiss Agency for Development and Cooperation, Federal Democratic Republic of Ethiopia and the Kenyan Government.
    [Show full text]
  • Study of Purine Metabolism in a Xanthinuric Female
    Study of Purine Metabolism in a Xanthinuric Female MICHAEL J. BRADFORD, IRWIN H. KRAKOFF, ROBERT LEEPER, and M. EARL BALis From the Sloan-Kettering Institute, Sloan-Kettering Division of Cornell University Graduate School of Medical Sciences, and the Department of Medicine of Memorial and James Ewing Hospitals, New York 10021 A B S TR A C T A case of xanthinuria is briefly de- Case report in brief. The patient is a 62 yr old scribed, and the results of in vivo studies with Puerto Rican grandmother, whose illness is de- 4C-labeled oxypurines are discussed. The data scribed in detail elsewhere.' Except for mild pso- demonstrate that the rate of the turnover of uric riasis present for 30 yr, she has been in good acid is normal, despite an extremely small uric health. On 26 June 1966, the patient was admitted acid pool. Xanthine and hypoxanthine pools were to the Second (Cornell) Medical Service, Bellevue measured and their metabolism evaluated. The Hospital, with a 3 day history of pain in the right bulk of the daily pool of 276 mg of xanthine, but foot and fever. The admission physical examina- only 6% of the 960 mg of hypoxanthine, is ex- tion confirmed the presence of monoarticular ar- creted. Thus, xanthine appears to be a metabolic thritis and mild psoriasis. The patient's course in end product, whereas hypoxanthine is an active the hospital was characterized by recurrent fevers intermediate. Biochemical implications of this find- to 104°F and migratory polyarthritis, affecting ing are discussed. both ankles, knees, elbows, wrists, and hands over a 6 wk period.
    [Show full text]
  • Fermentation of Acetylene by an Obligate Anaerobe, Pelobacter Acetylenicus Sp
    Archives of Arch Microbiol (1985) 142: 295- 301 Microbiology Springer-Verlag 1985 Fermentation of acetylene by an obligate anaerobe, Pelobacter acetylenicus sp. nov. * Bernhard Schink Fakult/it ffir Biologie, Universit/it Konstanz, Postfach 5560, D-7750 Konstanz, Federal Republic of Germany Abstract. Four strains of strictly anaerobic Gram-negative tion reactions (Schink 1985a). No significant anaerobic rod-shaped non-sporeforming bacteria were enriched and degradation could be observed with ethylene (ethene), the isolated from marine and freshwater sediments with acety- most simple unsaturated hydrocarbon (Schink 1985 a, b). lene (ethine) as sole source of carbon and energy. Acetylene, It was reported recently that also acetylene can be metab- acetoin, ethanolamine, choline, 1,2-propanediol, and glyc- olized in the absence of molecular oxygen (Watanabe and erol were the only substrates utilized for growth, the latter de Guzman 1980). Enrichment cultures with acetylene as two only in the presence of small amounts of acetate. Sub- sole carbon source were obtained in mineral media with strates were fermented by disproportionation to acetate and sulfate as electron acceptor, and acetate could be identified ethanol or the respective higher acids and alcohols. No as an intermediary metabolite (Culbertson et al. 1981). How- cytochromes were detectable; the guanine plus cytosine ever, these enrichment cultures were difficult to maintain, content of the DNA was 57.1 _+ 0.2 tool%. Alcohol dehy- and the acetylene-degrading bacteria could not be identified drogenase, aldehyde dehydrogenase, phosphate acetyl- (C. W. Culbertson and R. S. Oremland, Abstr. 3rd Int. transferase, and acetate kinase were found in high activities Syrup.
    [Show full text]
  • ATP-Dependent Substrate Reduction at an [Fe8s9] Double-Cubane Cluster
    ATP-dependent substrate reduction at an [Fe8S9] double-cubane cluster Jae-Hun Jeounga and Holger Dobbeka,1 aInstitut für Biologie, Strukturbiologie/Biochemie, Humboldt-Universität zu Berlin, D-10099 Berlin, Germany Edited by Amy C. Rosenzweig, Northwestern University, Evanston, IL, and approved February 2, 2018 (received for review November 23, 2017) Chemically demanding reductive conversions in biology, such as the We have characterized the two components of a widespread reduction of dinitrogen to ammonia or the Birch-type reduction of system of the third type and find that the electron-accepting – aromatic compounds, depend on Fe/S-cluster containing ATPases. component features a double-cubane [Fe8S9]-cluster. This [Fe8S9]- These reductions are typically catalyzed by two-component systems, cluster, so far unknown to biology, catalyzes reductive reactions in which an Fe/S-cluster–containing ATPase energizes an electron to otherwise associated only with the complex iron–sulfur clusters reduce a metal site on the acceptor protein that drives the reductive of nitrogenases. Our results reveal several parallels between the reaction. Here, we show a two-component system featuring a double-cubane cluster-containing enzymes and nitrogenases μ double-cubane [Fe8S9]-cluster [{Fe4S4(SCys)3}2( 2-S)]. The double- and suggest that an unexplored biochemical reactivity space cubane–cluster-containing enzyme is capable of reducing small mol- may be hidden among the diverse ATP-dependent two-component − ecules, such as acetylene (C2H2), azide (N3 ), and hydrazine (N2H4). enzymes. We thus present a class of metalloenzymes akin in fold, metal clus- ters, and reactivity to nitrogenases. Results Distribution of Double-Cubane Cluster Protein-Like Proteins.
    [Show full text]
  • Complete Deficiency of Adenine Phosphoribosyltransferase
    Arch Dis Child: first published as 10.1136/adc.54.1.25 on 1 January 1979. Downloaded from Archives of Disease in Childhood, 1979, 54, 25-31 Complete deficiency of adenine phosphoribosyltransferase A third case presenting as renal stones in a young child T. M. BARRATT, H. A. SIMMONDS, J. S. CAMERON, C. F. POTTER, G. A. ROSE, D. G. ARKELL, AND D. I. WILLIAMS Department of Medicine, Guy's Hospital, The Hospital for Sick Children, Great Ormond Street, and the Institute of Urology, St Philip's Hospital, London SUMMARY We report a third case of 2, 8-dihydroxyadenine stones in a child with a complete lack of the adenine salvage enzyme-adenine phosphoribosyltransferase (APRT). The propositus, a 20-month-old girl of consanguineous Arab parents, presented with multiple urinary tract infections and supposed 'uric acid' stones in the right renal pelvis and left ureter. Both parents and one brother were heterozygotes for the defect, in keeping with an autosomal recessive mode of inheritance. In contrast with the other purine salvage enzyme disorder of childhood with true uric acid stones (the Lesch-Nyhan syndrome), uric acid excretion was normal in all family members. As in our previous case, treatment with allopurinol, without alkali, has eliminated the urinary excretion of 2, 8-dihy- droxyadenine: the stones were removed surgically. 2, 8-Dihydroxyadenine should be considered in any child thought to have uric acid stones and tests made to distinguish the two compounds. Many urinary stones or crystals identified in children AMP IMP result from the overexcretion of normally minor http://adc.bmj.com/ urinary constituents, compounds of limited solubility whose overexcretion may be the direct consequence adenosine inosine of a block in an essential step in a metabolic pathway.
    [Show full text]
  • Xanthine Urolithiasis: Inhibitors of Xanthine Crystallization
    bioRxiv preprint doi: https://doi.org/10.1101/335364; this version posted May 31, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Xanthine urolithiasis: Inhibitors of xanthine crystallization Authors: Felix Grases, Antonia Costa-Bauza, Joan Roig, Adrian Rodriguez Laboratory of Renal Lithiasis Research, Faculty of Sciences, University Institute of Health Sciences Research (IUNICS-IdISBa), University of Balearic Islands, Ctra. de Valldemossa, km 7.5, 07122 Palma de Mallorca, Spain. Corresponding author: Felix Grases. Laboratory of Renal Lithiasis Research, Faculty of Sciences, University Institute of Health Sciences Research (IUNICS), University of Balearic Islands, Ctra. de Valldemossa, km 7.5, 07122 Palma de Mallorca, Spain. Telephone number: +34 971 17 32 57 e-mail: [email protected] Key words: xanthine lithiasis, 7-Methylxanthine, 3-Methylxanthine, Theobromine. 1 bioRxiv preprint doi: https://doi.org/10.1101/335364; this version posted May 31, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract OBJECTIVE. To identify in vitro inhibitors of xanthine crystallization that have potential for inhibiting the formation of xanthine crystals in urine and preventing the development of the renal calculi in patients with xanthinuria. METHODS. The formation of xanthine crystals in synthetic urine and the effects of 10 potential crystallization inhibitors were assessed using a kinetic turbidimetric system with a photometer.
    [Show full text]
  • Identification of Two Mutations in Human Xanthine Dehydrogenase Gene Responsible for Classical Type I Xanthinuria
    Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. K Ichida, … , T Hosoya, O Sakai J Clin Invest. 1997;99(10):2391-2397. https://doi.org/10.1172/JCI119421. Research Article Hereditary xanthinuria is classified into three categories. Classical xanthinuria type I lacks only xanthine dehydrogenase activity, while type II and molybdenum cofactor deficiency also lack one or two additional enzyme activities. In the present study, we examined four individuals with classical xanthinuria to discover the cause of the enzyme deficiency at the molecular level. One subject had a C to T base substitution at nucleotide 682 that should cause a CGA (Arg) to TGA (Ter) nonsense substitution at codon 228. The duodenal mucosa from the subject had no xanthine dehydrogenase protein while the mRNA level was not reduced. The two subjects who were siblings with type I xanthinuria were homozygous concerning this mutation, while another subject was found to contain the same mutation in a heterozygous state. The last subject who was also with type I xanthinuria had a deletion of C at nucleotide 2567 in cDNA that should generate a termination codon from nucleotide 2783. This subject was homozygous for the mutation and the level of mRNA in the duodenal mucosa from the subject was not reduced. Thus, in three subjects with type I xanthinuria, the primary genetic defects were confirmed to be in the xanthine dehydrogenase gene. Find the latest version: https://jci.me/119421/pdf Identification of Two Mutations
    [Show full text]
  • Substratstereochemie Und Untersuchungen Zum Mechanismus Der 4-Hydroxybutyryl-Coa-Dehydratase Aus Clostridium Aminobutyricum
    Substratstereochemie und Untersuchungen zum Mechanismus der 4-Hydroxybutyryl-CoA-Dehydratase aus Clostridium aminobutyricum Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften (Dr. rer. nat.) dem Fachbereich Biologie der Philipps-Universität Marburg vorgelegt von Peter Friedrich aus Marburg/Lahn Marburg/Lahn 2008 Die Untersuchungen zur vorliegenden Arbeit wurden von November 2003 bis November 2008 am Fachbereich Biologie der Philipps-Universität Marburg unter der Leitung von Herrn Prof. Dr. W. Buckel durchgeführt. Vom Fachbereich Biologie der Philipps-Universität Marburg als Dissertation am angenommen. Erstgutachter: Prof. Dr. W. Buckel Zweitgutachter: Prof. Dr. R. Thauer Tag der mündlichen Prüfung: 18.12.2008 für meine Familie für Christine Die Ergebnisse dieser Dissertation sind in folgenden Publikationen veröffentlicht: Friedrich P, Darley DJ, Golding BT, Buckel W (2008) The complete stereochemistry of the enzymatic dehydration of 4-hydroxybutyryl coenzyme A to crotonyl coenzyme A. Angew. Chem. Int. Ed. Engl. 47:3254-3257. Der stereochemische Verlauf der enzymatischen Wassereliminierung von 4-Hydroxybutyryl-Coenzym A zu Crotonyl- Coenzym A. Angew. Chem. 120:3298-3301 Martins BM, Messerschmidt A, Friedrich P, Zhang J, Buckel W (2007) 4-Hydroxybutyryl- CoA dehydratase. In: Messerschmidt A (ed) Handbook of Metalloproteins Online Edition. John Wiley & Sons Ltd., Sussex, UK. Publisched online Dez 2007 weitere Veröffentlichungen: Scott R, Näser U, Friedrich P, Selmer T, Buckel W, Golding BT (2004) Stereochemistry of hydrogen
    [Show full text]